Kirkeby Cell Therapy APS: Financial statements 2025
CVR: 38650165
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Kirkeby Cell Therapy APS (CVR 38650165) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 25,872 and a net result of DKK -19,504 compared with DKK 111,159 the year before. That is a decrease of 56.5% compared with the year before. Equity in the 2025 report amounted to DKK 1,541,351. The solvency ratio was 98.9%.
- Gross Profit
- DKK 25,872
- Profit/Loss
- DKK -19,504
- Equity
- DKK 1,541,351
- Total Assets
- DKK 1,559,069
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 26K | -20K | 1.5M | 0 |
| 2024 | - | 60K | 111K | 1.7M | - |
| 2023 | - | 287K | 234K | 1.7M | - |
| 2022 | - | 108K | 128K | 1.6M | - |
| 2021 | - | 247K | 281K | 1.6M | - |
Official annual report
How creditworthy is Kirkeby Cell Therapy APS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Kirkeby Cell Therapy APS has published its annual report for 2024. Gross profit came to DKK 59,518, and the net result was DKK 111,159.
About Kirkeby Cell Therapy APS
Kirkeby Cell Therapy APS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Kirkeby Cell Therapy IVS and Kirkeby Cell Therapey IVS. The management consists of Agnete Kirkeby. The company is owned by Agnete Kirkeby. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 25,872 and a net result of DKK -19,504 compared with DKK 111,159 the year before. Equity in the 2025 report amounted to DKK 1,541,351.